Respiratory capabilities

Respiratory Experience: 75 Studies in 3 Years

PAREXEL Early phase is highly experienced in performing respiratory studies. In the last three years alone we have performed over 75 early phase respiratory studies in our Phase I units in healthy volunteers and patient populations including COPD, asthma, rhinitis among others. We know that we can add great value to your respiratory device or compound development. Offering specialized expertise to your study design process along with dedicated recruiting specialists and rapid start up environments we can help you identify your strongest opportunities sooner.

PAREXEL Early Phase Can Switch Seasons on Demand

We understand that respiratory clinical drug development presents unique and tough challenges for your drug development teams. Recruiting COPD patients in winter time or asthmatics during hay fever season is tough. PAREXEL have identified a unique solution to make your planning easier. We believe we are the only CRO to offer early respiratory studies such as allergen challenge testing in both northern and southern hemispheres, so we can provide your team the ultimate benefit – we can offer you contingency planning so that if needed we can simply switch the season on demand and perform your study at a back up site on the opposite hemisphere.

Many Respiratory Capabilities, One Uncomplicated Partnership

Working with PAREXEL Early Phase is straightforward. We can provide you comprehensive solutions to manage your respiratory compound or device from First in Man through Proof of Concept. We offer many respiratory capabilities in-house including: